"The U.S. Food and Drug Administration today approved Cosentyx (secukinumab) to treat adults with moderate-to-severe plaque psoriasis.
Psoriasis is a skin condition that causes patches of skin redness and irritation. Psoriasis is"...
DOSAGE AND ADMINISTRATION
Comb the hair to remove scaly debris and after suitably parting, apply Dovonex® (calcipotriene solution) Scalp Solution, 0.005%, twice daily, only to the lesions, and rub in gently and completely, taking care to prevent the solution spreading onto the forehead. The safety and efficacy of Dovonex® (calcipotriene solution) Scalp Solution, 0.005%, have been demonstrated in patients treated for eight weeks.
Keep Dovonex® (calcipotriene solution) Scalp Solution, 0.005%, well away from the eyes. Avoid application of the solution to uninvolved scalp margins. Always wash hands thoroughly after use.
Dovonex® (calcipotriene solution) Scalp Solution, 0.005% is available in 60 mL plastic bottles N 0430-3030-15
Store at controlled room temperature 15° C - 25° C (59° F - 77° F). Avoid sunlight. Do not freeze.
Manufactured by : LEO Pharmaceutical Products, Ltd., Ballerup, Denmark. Marketed by: Warner Chilcott (US), Inc., Rockaway, NJ 07866 USA.
Last reviewed on RxList: 6/2/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Dovonex Scalp Information
Dovonex Scalp - User Reviews
Dovonex Scalp User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.